Logo image of EMX.CA

EMX ROYALTY CORP (EMX.CA) Stock Fundamental Analysis

TSX-V:EMX - TSX Venture Exchange - CA26873J1075 - Common Stock - Currency: CAD

3.28  -0.02 (-0.61%)

Fundamental Rating

4

EMX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 807 industry peers in the Metals & Mining industry. EMX has an average financial health and profitability rating. EMX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

EMX had negative earnings in the past year.
In the past year EMX had a positive cash flow from operations.
In the past 5 years EMX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: EMX reported negative operating cash flow in multiple years.
EMX.CA Yearly Net Income VS EBIT VS OCF VS FCFEMX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

EMX's Return On Assets of 0.13% is amongst the best of the industry. EMX outperforms 84.51% of its industry peers.
Looking at the Return On Equity, with a value of 0.17%, EMX belongs to the top of the industry, outperforming 85.13% of the companies in the same industry.
With an excellent Return On Invested Capital value of 1.40%, EMX belongs to the best of the industry, outperforming 88.72% of the companies in the same industry.
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROIC 1.4%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
EMX.CA Yearly ROA, ROE, ROICEMX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

Looking at the Profit Margin, with a value of 0.67%, EMX belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
The Operating Margin of EMX (9.93%) is better than 89.59% of its industry peers.
Industry RankSector Rank
OM 9.93%
PM (TTM) 0.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX.CA Yearly Profit, Operating, Gross MarginsEMX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EMX is destroying value.
Compared to 1 year ago, EMX has less shares outstanding
The number of shares outstanding for EMX has been increased compared to 5 years ago.
Compared to 1 year ago, EMX has a worse debt to assets ratio.
EMX.CA Yearly Shares OutstandingEMX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX.CA Yearly Total Debt VS Total AssetsEMX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

EMX has an Altman-Z score of 5.34. This indicates that EMX is financially healthy and has little risk of bankruptcy at the moment.
EMX has a better Altman-Z score (5.34) than 68.03% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that EMX is not too dependend on debt financing.
EMX has a Debt to Equity ratio of 0.30. This is in the lower half of the industry: EMX underperforms 68.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 5.34
ROIC/WACC0.16
WACC8.68%
EMX.CA Yearly LT Debt VS Equity VS FCFEMX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

EMX has a Current Ratio of 8.56. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
EMX has a better Current ratio (8.56) than 83.77% of its industry peers.
EMX has a Quick Ratio of 8.56. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 8.56, EMX belongs to the best of the industry, outperforming 83.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.56
Quick Ratio 8.56
EMX.CA Yearly Current Assets VS Current LiabilitesEMX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

EMX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.75%, which is quite impressive.
Looking at the last year, EMX shows a decrease in Revenue. The Revenue has decreased by -1.62% in the last year.
The Revenue has been growing by 40.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 63.03% on average per year.
EMX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.70% yearly.
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EMX.CA Yearly Revenue VS EstimatesEMX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX.CA Yearly EPS VS EstimatesEMX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

4

4. Valuation

4.1 Price/Earnings Ratio

EMX is valuated quite expensively with a Price/Forward Earnings ratio of 79.61.
EMX's Price/Forward Earnings ratio is rather cheap when compared to the industry. EMX is cheaper than 85.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.27. EMX is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 79.61
EMX.CA Price Earnings VS Forward Price EarningsEMX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

88.72% of the companies in the same industry are more expensive than EMX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.02
EMX.CA Per share dataEMX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EMX's earnings are expected to grow with 63.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.57%
EPS Next 3Y63.03%

0

5. Dividend

5.1 Amount

No dividends for EMX!.
Industry RankSector Rank
Dividend Yield N/A

EMX ROYALTY CORP

TSX-V:EMX (6/6/2025, 7:00:00 PM)

3.28

-0.02 (-0.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-11 2025-05-11/amc
Earnings (Next)08-11 2025-08-11
Inst Owners13.79%
Inst Owner ChangeN/A
Ins Owners15.07%
Ins Owner ChangeN/A
Market Cap354.31M
Analysts84.44
Price Target4.85 (47.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.56%
PT rev (3m)11.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 79.61
P/S 11.96
P/FCF N/A
P/OCF 50.04
P/B 3.07
P/tB 3.07
EV/EBITDA 38.02
EPS(TTM)0
EYN/A
EPS(NY)0.04
Fwd EY1.26%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.07
OCFY2%
SpS0.27
BVpS1.07
TBVpS1.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROCE 1.94%
ROIC 1.4%
ROICexc 1.69%
ROICexgc 1.69%
OM 9.93%
PM (TTM) 0.67%
GM N/A
FCFM N/A
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.69
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.09
Cash Conversion 75.55%
Profit Quality N/A
Current Ratio 8.56
Quick Ratio 8.56
Altman-Z 5.34
F-Score6
WACC8.68%
ROIC/WACC0.16
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A
EBIT growth 1Y-31.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2186.51%
EBIT Next 3Y205.17%
EBIT Next 5YN/A
FCF growth 1Y44.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y220.22%
OCF growth 3YN/A
OCF growth 5YN/A